Connect with us

Business

ASX to dip ahead of RBA interest rate decision – Yahoo Finance Australia

Here’s Yahoo Finance’s Tuesday morning wrap.

Published

on

post featured image

SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Progenity) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it has commenced an underwritten public offering of $25 million of shares of its common stock. In addition, Progenity is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $3.75 million of shares…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending